Need for more intensive treatment of patients with acute pulmonary embolism caused by heparin-induced thrombocytopaenia Type II

Eur Heart J. 2005 Dec;26(24):2745-6. doi: 10.1093/eurheartj/ehi610. Epub 2005 Oct 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects*
  • Heparin, Low-Molecular-Weight / adverse effects*
  • Humans
  • Pulmonary Embolism / chemically induced*
  • Risk Factors
  • Thrombocytopenia / chemically induced*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight